GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » Cash Receipts from Operating Activities

GH Research (STU:1KA) Cash Receipts from Operating Activities


View and export this data going back to 2024. Start your Free Trial

What is GH Research Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


GH Research Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » Cash Receipts from Operating Activities
Traded in Other Exchanges
Address
Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.